Biofourmis’ Biovitals Analytics Engine Receives FDA’s 510(k) Clearance for Ambulatory Physiologic Monitoring

 Biofourmis’ Biovitals Analytics Engine Receives FDA’s 510(k) Clearance for Ambulatory Physiologic Monitoring

Biofourmis’ Biovitals Analytics Engine Receives FDA’s 510(k) Clearance for Ambulatory Physiologic Monitoring

Shots:

  • The US FDA has approved machine learning and AI-based Biofourmis’ Biovitals Analytics Engine as a medical device for ambulatory physiological monitoring 
  • The approval follows the approval of its Rhythm Analytics platform, cloud-based software for automated interpretation of 15+ types of cardiac arrhythmias in May’2019. The approval establishes the AI-powered solution as the foundation for Biofourmis’ digital therapeutics product pipeline
  • The Biovitals Analytics Engine within the context of the Biovitals HF platform helps to find the critical unmet medical needs in heart failure care

Click here to­ read full press release/ article | Ref: PRNewswire | Image: Pharmaceutical Technology

Vartika Singh

Vartika Singh is a content writer who loves to write research articles and reports at PharmaShots. She has in-depth knowledge of the life sciences industry including the Pharma and Biotech sectors. Any articles written by her can be contacted at connect@pharmashots.com.

Related post